Metoclopramide as an analgesic in severe migraine attacks: An open, single-blind, parallel control study

Recent Patents on CNS Drug Discovery

Volumn 6, Issue 2, 2011, Pages 141-145

  Salazar, Gabriel ^a   Fragoso, Marta ^a   Vergez, Luis ^b   Sergio, Piera ^c   Cuello, Denisse ^a  

^a Hospital CST   (Spain)

^b Manresa General Hospital   (Spain)

^c Hospital de Igualada   (Spain)

Author keywords

Dopamine antagonist; Headache; Metoclopramide; Migraine

Indexed keywords

METOCLOPRAMIDE; PARACETAMOL;

ADULT; AKATHISIA; ALLERGIC RASH; ANXIETY; ARTICLE; DEPRESSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOMNOLENCE;

ACETAMINOPHEN; ADULT; ANALGESICS; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIGRAINE DISORDERS; SINGLE-BLIND METHOD;

EID: 79959362872     PISSN: 15748898     EISSN: 15748898     Source Type: Journal    
DOI: 10.2174/157488911795933947     Document Type: Article

References (34)

1. Thomas AW, Donald LK, Michael JP, Eugene MW, Robert MC. Possible mechanism of action of metoclopramide-induced aldosterone secretion: In vivo and in vitro studies in the sheep. Endocrinology 1983; 113(3): 887-92.
2. Desmond PV, Watson KJ. Metoclopramide - A review. Med J Aust 1986; 144(7): 366-9.
3. DiPalma JR. Metoclopramide: A dopamine receptor antagonist. Am Fam Physician 1990; 41(3): 919-24.
4. Plachetka, J.R. Treatment of migraine. US7030162 (2006).
5. Colman I, Brown M, Innes G, Grafstein E, Roberts T, Rowe B. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 2004; 329: 1369.
6. Allena M, Magis D, Schoenen J. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurol 2005; 65(8):1339-40.
7. Hakkarainen H, Allonen H. Ergotamine vs. metoclopramide vs. their combination in acute migraine attacks. Headache 1982; 22(1): 10-2.
8. Loder EW. Review: Intravenous metoclopramide is better than placebo for reducing pain in acute migraine in the emergency department. ACP J Club 2005; 142(3): 77.
9. Pauletti, G.M. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs. US7744916 (2010).
10. Salazar G, Huertas A, Vergez L, Ramos A, Lluch J. Metoclopramide as a painkiller for intense migraine headache in emergency. Rev Neurol 2008; 47 (10): 506-8.
11. Olesen J, Steiner T. The international classification of headache disorders, 2nd end (ICDH-II). J Neurol Neurosurg Psychiatry 2004; 75: 808-11.
12. Stewart W, Lipton R, Kolodner K. Migraine disability assessment (MIDAS) score: Relation to headache frequency, pain intensity, and headache symptoms. Headache 2003; 43(3): 258-65.
13. Cady R, Dodick DW. Diagnosis and treatment of migraine. Mayo Clinic Proc 2002; 77 (3): 255-61.
14. Dooley M, Faulds D. Rizatriptan: A review of its efficacy in the management of migraine. Drugs 1999; 58: 699-723.
15. Stark S, Spierings EL, McNeal S, Putnam GP, Bolden-Watson CP, O'Quinn S. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache 2000; 40: 513-20.
16. Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: A comparative open trial. Headache 2000; 40: 464-5.
17. Stephen D, Silberstein MD. FACP and for the US headache consortium. practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) report of the quality standards subcommittee of the american academy of neurology. Neurol 2000; 55: 754-62.
18. [Oldman A, Smith L, McQuay H, Moore R. Pharmacological treatments for acute migraine. Quantitative systematic review. Pain 97(3): 247-57.
19. Sands, G. 5HT 1 receptor agonists and metoclopramide for the treatment of migraine. US6255334 (2001).
20. Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D. Marketed oral triptans in the acute treatment of migraine: A systematic review on efficacy and tolerability. Headache 2007; 47(8):1152-68.
21. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22(8): 633-58.
22. De Sousa SC, Karwautz A, Wöber C, Wagner G, Breen G, Zesch HE, et al. A dopamine D4 receptor exon 3 VNTR allele protecting against migraine without aura. Ann Neurol 2007; 61(6): 574-8.
23. Akerman S, Goadsby PJ. The role of dopamine in a model of trigeminovascular nociception. J Pharmacol Exp Ther 2005; 314(1):162-9.
24. Fanciullacci M, Alessandri M, Del Rosso. Dopamine involvement in the migraine attack. Funct Neurol 2000; 15 (Suppl 3): 171-81.
25. Friedman BW, Esses D, Solorzano C, Dua N, Greenwald P, Radulescu R, et al. A randomized controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med 2008; 52(4): 399-406.
26. Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study. Headache 2006; 46(5): 781-7.
27. Kelly AM, Walcynski T, Gunn B. The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis Headache 2009; 49(9):1324-32.
28. Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 2004; 329(7479):1369-73.
29. Parlak I, Erdur B, Parlak M, Ergin A, Turkcuer I, Tomruk O, et al. Intravenous administration of metoclopramide by 2 min bolus vs 15 min infusion: Does it affect the improvement of headache while reducing the side effects? Postgrad Med J 2007; 83(984): 664-8.
30. Friedman BW, Corbo J, Lipton RB, Bijur PE, Esses D, Solorzano C, et al. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology 2005; 64(3): 463-8.
31. Coppola M, Yealy DM, Leibold RA. Randomized, placebocontrolled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med 1995; 26(5): 541-6.
32. Azzopardi TD, Brooks NA. Oral metoclopramide as an adjunct to analgesics for the outpatient treatment of acute migraine. Ann Pharmacother 2008; 42(3): 397-402.
33. Agosti RM. 5HT1F- and 5HT7-receptor agonists for the treatment of migraines. CNS Neurol Disord Drug Targets 2007; 6(4): 235-7.
34. Lee, D. Combination of quetiapine and zolmitriptan. US20080108596 (2008).